Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01351103
Title	A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Novartis Pharmaceuticals
Indications	head and neck cancer cervical squamous cell carcinoma head and neck squamous cell carcinoma triple-receptor negative breast cancer pancreatic cancer lung squamous cell carcinoma esophagus squamous cell carcinoma melanoma colorectal cancer pancreatic adenocarcinoma Advanced Solid Tumor
Therapies	LGK974 LGK974 + Spartalizumab
Age Groups:	senior \| adult
Covered Countries	USA \| NLD \| ITA \| FRA \| ESP \| DEU \| CAN